Nifty
:
23161.60
Sensex
:
73832.55
-53.35 (-0.23%)
-150.63 (-0.20%)
Nifty
Sensex
:
:
23161.60
73832.55
-53.35 (-0.23%)
-150.63 (-0.20%)

Kwality Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :
79/99

BSE: 539997 | NSE: KPL

NSE BSE
2362.40
11-Jun-2026
  • Open
  • High
  • Low
  • Previous Close
  •  2544
  •  2548.9
  •  2325
  •  2506.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  46724
  •  114600979.8
  •  2600
  •  1561

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,462.01
  • 36.56
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,588.88
  • N/A
  • 7.44

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.87%
  • 1.22%
  • 31.64%
  • FII
  • DII
  • Others
  • 2.79%
  • 0.00%
  • 9.48%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.44
  • 7.16
  • 13.82

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 31.99
  • 22.75
  • 5.77

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 38.36
  • 21.33
  • 27.17

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.82
  • 26.01
  • 27.48

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.11
  • 4.55
  • 3.24

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.39
  • 11.25
  • 11.40

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
157.11
115.68
35.81%
123.44
84.41
46.24%
111.05
90.03
23.35%
111.48
80.08
39.21%
Expenses
118.35
89.79
31.81%
93.49
66.91
39.73%
85.70
70.37
21.78%
87.30
62.74
39.15%
EBITDA
38.76
25.89
49.71%
29.95
17.50
71.14%
25.35
19.66
28.94%
24.18
17.34
39.45%
EBIDTM
24.67%
22.38%
24.26%
20.73%
22.83%
21.84%
21.69%
21.66%
Other Income
1.06
0.77
37.66%
0.53
0.66
-19.70%
0.90
0.22
309.09%
0.38
0.28
35.71%
Interest
2.89
2.49
16.06%
2.48
2.20
12.73%
2.84
2.71
4.80%
2.76
2.48
11.29%
Depreciation
5.26
5.09
3.34%
4.82
4.56
5.70%
4.96
4.62
7.36%
4.76
4.03
18.11%
PBT
31.67
19.07
66.07%
22.34
11.39
96.14%
18.45
12.55
47.01%
17.03
11.12
53.15%
Tax
6.36
4.59
38.56%
6.35
2.87
121.25%
4.34
4.10
5.85%
5.11
2.77
84.48%
PAT
25.31
14.48
74.79%
16.00
8.52
87.79%
14.11
8.46
66.78%
11.92
8.35
42.75%
PATM
16.11%
12.52%
12.96%
10.10%
12.71%
9.39%
10.69%
10.42%
EPS
24.38
13.96
74.64%
15.43
8.22
87.71%
13.60
8.16
66.67%
11.49
8.05
42.73%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
503.08
370.20
307.17
251.03
456.19
262.01
139.30
166.29
137.49
98.32
74.17
Net Sales Growth
35.89%
20.52%
22.36%
-44.97%
74.11%
88.09%
-16.23%
20.95%
39.84%
32.56%
 
Cost Of Goods Sold
258.43
116.19
89.63
69.44
141.83
165.59
87.08
119.44
101.59
71.29
56.77
Gross Profit
244.65
254.00
217.55
181.59
314.36
96.42
52.22
46.85
35.91
27.03
17.40
GP Margin
48.63%
68.61%
70.82%
72.34%
68.91%
36.80%
37.49%
28.17%
26.12%
27.49%
23.46%
Total Expenditure
384.84
289.81
240.86
190.30
284.52
233.16
125.10
150.59
125.82
89.44
69.16
Power & Fuel Cost
-
23.37
17.23
12.98
11.07
6.13
4.20
3.71
2.71
2.81
2.31
% Of Sales
-
6.31%
5.61%
5.17%
2.43%
2.34%
3.02%
2.23%
1.97%
2.86%
3.11%
Employee Cost
-
41.26
30.46
28.16
18.80
14.70
10.92
7.74
4.89
3.60
2.16
% Of Sales
-
11.15%
9.92%
11.22%
4.12%
5.61%
7.84%
4.65%
3.56%
3.66%
2.91%
Manufacturing Exp.
-
71.16
75.33
50.12
68.38
7.02
3.54
2.87
5.16
2.64
1.56
% Of Sales
-
19.22%
24.52%
19.97%
14.99%
2.68%
2.54%
1.73%
3.75%
2.69%
2.10%
General & Admin Exp.
-
18.07
17.66
16.11
10.95
12.85
8.48
5.83
3.19
2.61
2.63
% Of Sales
-
4.88%
5.75%
6.42%
2.40%
4.90%
6.09%
3.51%
2.32%
2.65%
3.55%
Selling & Distn. Exp.
-
18.22
8.71
12.66
33.27
25.90
10.60
10.79
8.07
5.04
3.29
% Of Sales
-
4.92%
2.84%
5.04%
7.29%
9.89%
7.61%
6.49%
5.87%
5.13%
4.44%
Miscellaneous Exp.
-
1.52
1.83
0.83
0.23
0.97
0.28
0.19
0.23
1.46
3.29
% Of Sales
-
0.41%
0.60%
0.33%
0.05%
0.37%
0.20%
0.11%
0.17%
1.48%
0.59%
EBITDA
118.24
80.39
66.31
60.73
171.67
28.85
14.20
15.70
11.67
8.88
5.01
EBITDA Margin
23.50%
21.72%
21.59%
24.19%
37.63%
11.01%
10.19%
9.44%
8.49%
9.03%
6.75%
Other Income
2.87
1.92
1.83
2.94
3.51
1.59
3.66
0.61
0.80
1.21
0.36
Interest
10.97
9.88
10.39
6.61
2.92
2.68
2.50
2.28
2.20
1.93
1.21
Depreciation
19.80
18.29
19.56
14.96
10.69
6.49
4.43
3.12
2.98
2.51
1.69
PBT
89.49
54.14
38.20
42.10
161.57
21.27
10.92
10.91
7.30
5.65
2.48
Tax
22.16
14.34
7.48
6.29
41.63
6.38
2.71
3.35
2.87
2.37
1.19
Tax Rate
24.76%
26.49%
24.05%
24.60%
25.77%
30.00%
24.82%
30.71%
39.32%
41.95%
47.98%
PAT
67.34
39.84
23.80
19.37
119.99
15.15
8.32
7.56
4.54
3.37
1.55
PAT before Minority Interest
67.35
39.80
23.62
19.28
119.94
14.89
8.21
7.56
4.42
3.28
1.28
Minority Interest
0.01
0.04
0.18
0.09
0.05
0.26
0.11
0.00
0.12
0.09
0.27
PAT Margin
13.39%
10.76%
7.75%
7.72%
26.30%
5.78%
5.97%
4.55%
3.30%
3.43%
2.09%
PAT Growth
69.15%
67.39%
22.87%
-83.86%
692.01%
82.09%
10.05%
66.52%
34.72%
117.42%
 
EPS
64.75
38.31
22.88
18.63
115.38
14.57
8.00
7.27
4.37
3.24
1.49

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
264.05
224.21
200.52
181.14
61.15
46.01
37.30
29.75
25.58
21.76
Share Capital
10.38
10.38
10.38
10.38
10.38
10.38
10.38
10.38
5.19
5.01
Total Reserves
253.67
213.84
190.14
170.77
50.78
35.63
26.92
19.37
20.40
16.75
Non-Current Liabilities
13.76
19.75
28.62
21.32
28.08
19.78
8.23
5.47
4.24
3.32
Secured Loans
15.12
19.56
27.19
19.59
16.26
8.18
7.01
3.11
2.63
2.35
Unsecured Loans
0.00
0.00
0.12
0.70
2.00
2.00
0.58
1.59
0.67
0.35
Long Term Provisions
0.25
0.22
0.90
0.75
0.68
0.62
0.52
0.55
0.54
0.17
Current Liabilities
169.50
151.85
125.95
139.49
78.29
67.75
60.83
61.98
41.60
26.54
Trade Payables
55.79
44.32
35.19
34.51
26.21
22.97
17.07
22.14
12.74
9.67
Other Current Liabilities
24.28
34.91
33.31
40.97
29.82
20.55
21.73
15.91
11.46
5.94
Short Term Borrowings
83.33
66.02
50.96
23.00
16.45
21.24
18.73
21.33
15.09
9.65
Short Term Provisions
6.10
6.60
6.48
41.00
5.80
3.00
3.30
2.60
2.30
1.28
Total Liabilities
445.66
394.18
353.64
340.60
166.22
132.50
105.38
96.21
70.92
51.21
Net Block
145.69
139.05
120.50
91.73
56.53
42.69
22.60
16.48
15.65
12.72
Gross Block
231.57
206.64
170.15
128.13
82.22
62.60
41.16
31.92
28.22
22.78
Accumulated Depreciation
85.87
67.58
49.65
36.39
25.69
19.91
18.56
15.44
12.56
10.06
Non Current Assets
161.88
151.49
146.43
112.77
60.33
43.46
29.99
21.14
17.75
12.88
Capital Work in Progress
0.00
0.00
14.29
12.15
2.89
0.00
6.48
3.90
1.36
0.00
Non Current Investment
0.00
0.00
0.00
0.00
0.73
0.65
0.79
0.63
0.62
0.03
Long Term Loans & Adv.
16.19
12.44
10.71
8.11
0.17
0.12
0.12
0.12
0.12
0.12
Other Non Current Assets
0.00
0.00
0.93
0.78
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
283.78
242.69
207.20
227.82
105.90
89.03
75.35
75.00
53.07
38.19
Current Investments
0.00
0.00
0.00
0.00
4.44
3.34
4.04
4.71
3.03
1.91
Inventories
83.47
78.39
86.31
53.36
17.36
22.42
11.25
15.03
13.85
10.35
Sundry Debtors
154.31
114.39
71.69
69.13
35.71
30.33
38.43
37.03
22.61
18.03
Cash & Bank
14.76
5.94
7.36
12.95
5.81
1.54
1.40
1.61
2.99
1.35
Other Current Assets
31.25
7.03
0.00
0.00
42.58
31.41
20.24
16.61
10.58
6.56
Short Term Loans & Adv.
31.25
36.94
41.83
92.38
42.49
31.29
20.18
16.49
10.53
6.50
Net Current Assets
114.27
90.84
81.25
88.33
27.61
21.28
14.52
13.02
11.47
11.65
Total Assets
445.66
394.18
353.63
340.59
166.23
132.49
105.37
96.21
70.92
51.21

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
52.72
42.98
41.38
60.60
26.71
6.16
13.58
-0.57
4.30
-2.85
PBT
54.14
31.10
25.57
161.57
21.27
10.92
10.91
7.30
5.65
2.48
Adjustment
28.00
36.62
20.95
13.56
9.09
7.09
5.22
4.36
4.69
3.25
Changes in Working Capital
-13.63
-23.44
1.01
-73.18
2.72
-9.13
0.89
-9.17
-3.62
-7.31
Cash after chg. in Working capital
68.51
44.28
47.54
101.95
33.09
8.87
17.02
2.49
6.72
-1.58
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-15.79
-1.30
-6.16
-41.35
-6.38
-2.71
-3.44
-3.06
-2.42
-1.26
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-28.52
-26.40
-48.44
-62.93
-23.20
-17.80
-11.78
-6.20
-7.26
-2.47
Net Fixed Assets
-24.54
-22.20
-44.16
-55.17
-22.50
-14.92
-11.81
-6.25
-6.79
Net Investments
0.00
0.00
0.00
5.17
-1.18
0.92
0.08
-1.87
-1.99
Others
-3.98
-4.20
-4.28
-12.93
0.48
-3.80
-0.05
1.92
1.52
Cash from Financing Activity
-14.44
-17.40
0.99
5.66
0.77
11.77
-2.00
5.39
4.60
5.63
Net Cash Inflow / Outflow
9.76
-0.81
-6.07
3.33
4.27
0.14
-0.21
-1.38
1.65
0.31
Opening Cash & Equivalents
2.26
3.07
9.13
5.81
1.54
1.40
1.61
2.99
1.35
1.03
Closing Cash & Equivalent
12.02
2.26
3.07
9.13
5.81
1.54
1.40
1.61
2.99
1.35

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
253.70
215.31
192.48
173.81
58.16
43.57
35.14
27.83
23.79
20.78
ROA
9.48%
6.32%
5.55%
47.33%
9.97%
6.90%
7.50%
5.29%
5.37%
2.90%
ROE
16.36%
11.16%
10.15%
99.66%
28.21%
20.10%
23.13%
16.51%
14.41%
6.54%
ROCE
18.36%
13.57%
12.27%
95.32%
26.36%
18.49%
21.91%
19.19%
19.74%
12.45%
Fixed Asset Turnover
1.69
1.63
1.68
4.34
3.62
2.53
3.98
4.20
3.76
3.23
Receivable days
132.46
110.56
102.38
41.94
46.00
90.08
82.82
79.17
75.44
66.62
Inventory Days
79.79
97.85
101.54
28.29
27.71
44.10
28.84
38.34
44.92
41.35
Payable days
157.23
161.90
183.20
78.14
54.20
56.97
49.86
49.48
45.68
36.66
Cash Conversion Cycle
55.02
46.51
20.73
-7.91
19.51
77.22
61.80
68.03
74.67
71.31
Total Debt/Equity
0.43
0.44
0.45
0.35
0.68
0.77
0.79
0.92
0.77
0.62
Interest Cover
6.48
3.99
4.87
56.38
8.93
5.32
5.76
4.31
3.89
3.02

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Kwality Pharma - Quarterly Results
    20th May 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.